HHLR ADVISORS, LTD.
Institutional investor · Portfolio as of Q4 2024
Top Holdings45 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
BEIGENE LTD-ADR | 3.8M | $702.7M | 24.3% | $134.02 | +37.15% | 25 qtrssince 2018-Q4 | Decreased 0 |
ALIBABA GROUP HOLDING-SP ADR | 4.9M | $414.4M | 14.4% | $83.58 | -1.14% | 11 qtrssince 2022-Q2 | Decreased 0 |
PDD HOLDINGS INC | 2.7M | $264.8M | 9.2% | $97.08 | -2.77% | 11 qtrssince 2022-Q2 | Decreased 0 |
NETEASE INC-ADR | 2.6M | $231M | 8.0% | $90.10 | -3.46% | 9 qtrssince 2022-Q4 | Unchanged 0 |
KE HOLDINGS INC-ADR | 11.3M | $207.4M | 7.2% | $21.84 | -17.34% | 18 qtrssince 2020-Q3 | Increased 63 |
VIPSHOP HLDGS LTD | 14.9M | $200.4M | 6.9% | $12.69 | +0.75% | 16 qtrssince 2021-Q1 | Decreased 0 |
Legend Biotech Corp. Sponsored ADR | 6M | $194.7M | 6.7% | $50.33 | -34.89% | 19 qtrssince 2020-Q2 | Decreased 0 |
ARRIVENT BIOPHARMA INC | 4.5M | $119.5M | 4.1% | $17.95 | +50.18% | 4 qtrssince 2024-Q1 | Unchanged 0 |
FUTU HLDGS LTD | 1.1M | $89.5M | 3.1% | $70.95 | +13.48% | 3 qtrssince 2024-Q2 | Increased 59 |
WNS HLDGS LTD | 1.5M | $72.6M | 2.5% | — | — | 1 qtr | New 78 |
TRIP.COM GROUP LTD-ADR | 913,842 | $62.7M | 2.2% | $49.90 | +36.83% | 3 qtrssince 2024-Q2 | Decreased 0 |
JD.COM INC-ADR | 1.7M | $58.6M | 2.0% | $38.34 | -13.20% | 25 qtrssince 2018-Q4 | Increased 54 |
ENFUSION INC | 5M | $51.2M | 1.8% | — | — | 13 qtrssince 2021-Q4 | Unchanged 0 |
CYTEK BIOSCIENCES INC | 6.7M | $43.2M | 1.5% | $20.96 | -68.75% | 14 qtrssince 2021-Q3 | Unchanged 0 |
KINIKSA PHARMACEUTICALS INTL | 1.6M | $31.3M | 1.1% | $18.67 | +311.09% | 3 qtrssince 2024-Q2 | Unchanged 0 |
BRIDGEBIO PHARMA INC | 1M | $28.1M | 1.0% | $28.21 | +183.24% | 23 qtrssince 2019-Q2 | Unchanged 0 |
YATSEN HLDG LTD | 6.9M | $27.4M | 0.9% | $10.59 | -61.29% | 17 qtrssince 2020-Q4 | Decreased 0 |
CONTINEUM THERAPEUTICS INC | 669,337 | $9.8M | 0.3% | $17.61 | -17.83% | 3 qtrssince 2024-Q2 | Unchanged 0 |
AGORA INC | 2.1M | $8.7M | 0.3% | $4.20 | 0.00% | 1 qtr | New 47 |
ZTO EXPRESS CAYMAN INC | 435,927 | $8.5M | 0.3% | $23.65 | -20.06% | 8 qtrssince 2023-Q1 | Decreased 0 |
HHLR ADVISORS, LTD. manages $2.9B across 45 positions as of Q4 2024. Top holdings: ONC (24.3%), BABA (14.4%), PDD (9.2%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2/5.0.
Active quarter - 5 new positions, 8 exits, 10 increased. Top move: WNS (NEW, conviction 78). Portfolio: $2.9B across 45 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer